1999
DOI: 10.1055/s-2007-996422
|View full text |Cite
|
Sign up to set email alerts
|

Monitoring Therapy with Anticoagulants in The Netherlands

Abstract: In The Netherlands, the monitoring of outpatients on oral anticoagulant treatment is conducted, in 95% of the cases, by specialized centers, the so-called "trombosediensten." These centers are recognized by the Ministry of Public Health, Welfare and Sports and must satisfy certain standards and requirements. The centers are united in the "Federatie van Nederlandse Trombosediensten" that provides support in quality assessment and is a board for the negotiations with the government and other authorities. An atte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
12
0

Year Published

2000
2000
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(12 citation statements)
references
References 3 publications
0
12
0
Order By: Relevance
“…9 This has led to an improved management of OAT, resulting in a decrease in thromboembolic and bleeding complications. Frequent monitoring of prothrombin time (PT)/INR values continues to be an important part of the treatment, but it has physical, psychological, social, and financial conse-…”
Section: Arch Internmentioning
confidence: 99%
“…9 This has led to an improved management of OAT, resulting in a decrease in thromboembolic and bleeding complications. Frequent monitoring of prothrombin time (PT)/INR values continues to be an important part of the treatment, but it has physical, psychological, social, and financial conse-…”
Section: Arch Internmentioning
confidence: 99%
“…Many patients treated with oral anticoagulants benefit from education regarding this treatment [ 31 , 32 ]. European guidelines on cardiovascular disease prevention in clinical practice recommend to consider patients’ habits and preferences [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…It has been estimated that 2·3% of people older than 40 years and 5·9% of those older than 65 years suffer from atrial fibrillation (Feinberg et al , 1995). In Cambridge, UK, 0·5% of the population take warfarin (Baglin, 1998), while the Dutch Thrombosis Service monitors the anticoagulation of 270 000 persons annually (1·8% of a population of 15 million) (Breukink‐Engbers, 1999).…”
mentioning
confidence: 99%